PAREXEL
PAREXEL
PAREXEL International is a global provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today.
Revenue(RF), mln.USD
23
Assets(RF), mln.USD
14
Capital(RF), mln.USD
10
Staff(RF), 2021
294
Taxes(RF), mln.USD
3
The Company Statement
Received revenues in Russia in 2021, there is no any official announcement
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner